文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2020 - 2023年维多利亚市新冠病毒病疫苗接种状况及与该病死亡相关的因素:横断面研究

COVID-19 vaccination status and factors associated with deaths from the disease, Vitória, 2020-2023: cross-sectional study.

作者信息

Comerio Tatiane, Cola João Paulo, Mascarello Keila Cristina, Sales Carolina Maia Martins, Freire Brenda Silva, Vasconcelos Adjane da Silva, Souza Marcia Christina de, Maciel Ethel Leonor Noia

机构信息

Universidade Federal do Espírito Santo, Programa de Pós-Graduação em Saúde Coletiva, Vitória, ES, Brzsil.

Secretaria Municipal de Saúde, Vitória, ES, Brazil.

出版信息

Epidemiol Serv Saude. 2025 Aug 8;34:e20240700. doi: 10.1590/S2237-96222025v34e20240700.en. eCollection 2025.


DOI:10.1590/S2237-96222025v34e20240700.en
PMID:40802385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12342725/
Abstract

OBJECTIVE: To analyze the vaccination status against COVID-19 and factors associated with deaths from the disease. METHOD: Cross-sectional study with secondary data on deaths from COVID-19 in the city of Vitória, Espírito Santo, between February 2020 and December 2023. Individuals under 18 years of age and those with unavailable vaccination status were excluded. Relative and absolute frequencies were calculated by vaccination status. Poisson regression was used to calculate crude and adjusted prevalence ratios (PR) and 95% confidence intervals (95% CI). RESULTS: A total of 1,460 deaths were included, of which 244 (16.7%) had received ≥2 doses of the vaccines. Among the unvaccinated individuals, the highest frequency of deaths was recorded in individuals aged 60 to 79 years (47.9%), male (56.4%), and non-white race/skin color (53.0%). The PR of death in vaccinated individuals was higher in people ≥80 years old (PR 5.55; 95%CI 2.92; 10.55), 60-79 years old (PR 3.61; 95%CI 1.95; 6.69), with chronic lung disease (PR 1.35; 95%CI 1.03; 1.78) or chronic neurological disease (PR 1.37; 95%CI 1.08; 1.72), respiratory distress (PR 1.51; 95%CI 1.02; 2.23), desaturation (PR 1.97; 95%CI 1.35; 2.88) and adynamia (PR 2.80; 95%CI 2.02; 3.90). People with 1-4 years of schooling (PR 0.63; 95%CI 0.44; 0.90), 5-8 years of schooling (PR 0.57; 95%CI 0.39; 0.84), ≥8 years of schooling (PR 0.66; 95%CI 0.45; 0.97) had a lower prevalence. CONCLUSION: The highest prevalence of deaths among vaccinated individuals was associated with age ≥60 years, chronic lung or neurological disease, respiratory distress, desaturation, and adynamia. Loss of immunological memory in the elderly indicates the need for vaccine boosters to prevent deaths.

摘要

目的:分析新冠病毒疫苗接种情况以及与该疾病死亡相关的因素。 方法:采用横断面研究,利用2020年2月至2023年12月间圣埃斯皮里图州维多利亚市新冠病毒死亡病例的二手数据。排除18岁以下个体以及疫苗接种情况不明者。按疫苗接种情况计算相对频率和绝对频率。采用泊松回归计算粗患病率比(PR)和调整患病率比以及95%置信区间(95%CI)。 结果:共纳入1460例死亡病例,其中244例(16.7%)接种了≥2剂疫苗。在未接种疫苗的个体中,60至79岁(47.9%)、男性(56.4%)和非白人种族/肤色(53.0%)的死亡频率最高。≥80岁(PR 5.55;95%CI 2.92;10.55)、60 - 79岁(PR 3.61;95%CI 1.95;6.69)、患有慢性肺病(PR 1.35;95%CI 1.03;1.78)或慢性神经疾病(PR 1.37;95%CI 1.08;1.72)、呼吸窘迫(PR 1.51;95%CI 1.02;2.23)、血氧饱和度降低(PR 1.97;95%CI 1.35;2.88)和肌无力(PR 2.80;95%CI 2.02;3.90)的接种疫苗个体的死亡PR较高。接受1 - 4年教育(PR 0.63;95%CI 0.44;0.90)、5 - 8年教育(PR 0.57;95%CI 0.39;0.84)、≥8年教育(PR 0.66;95%CI 0.45;0.97)的个体患病率较低。 结论:接种疫苗个体中死亡的最高患病率与年龄≥60岁、慢性肺病或神经疾病、呼吸窘迫、血氧饱和度降低和肌无力有关。老年人免疫记忆丧失表明需要加强疫苗接种以预防死亡。

相似文献

[1]
COVID-19 vaccination status and factors associated with deaths from the disease, Vitória, 2020-2023: cross-sectional study.

Epidemiol Serv Saude. 2025-8-8

[2]
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.

JAMA Netw Open. 2024-7-1

[3]
Associations between obesity and sociodemographic, behavioral, and health characteristics in a population of women: a population-based study in Vitória, Espirito Santo, Brazil.

Front Public Health. 2025-6-11

[4]
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.

Cochrane Database Syst Rev. 2018-5-9

[5]
Parental hesitancy on COVID-19 vaccination of children under the age of 16: A cross-sectional mixed-methods study among factory workers.

PLoS One. 2025-6-26

[6]
Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.

PLoS Med. 2023-6

[7]
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.

MMWR Surveill Summ. 2025-6-12

[8]
Neurological manifestations of acute SARS-CoV-2 infection in a reference hospital in Bahia, Brazil.

Braz J Infect Dis. 2025-5-26

[9]
COVID-19 Vaccination and Odds of Post-COVID-19 Condition Symptoms in Children Aged 5 to 17 Years.

JAMA Netw Open. 2025-2-3

[10]
Real-world impact of COVID-19 vaccination, household exposure, and circulating SARS-CoV-2 variants on infection risk and symptom presentation in a U.S./Mexico border community.

Front Public Health. 2025-6-9

本文引用的文献

[1]
COVID-19 vaccines: Immune correlates and clinical outcomes.

Hum Vaccin Immunother. 2024-12-31

[2]
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales.

Lancet Reg Health Eur. 2023-12-12

[3]
The impact of COVID-19 vaccination in the US: Averted burden of SARS-COV-2-related cases, hospitalizations and deaths.

PLoS One. 2023

[4]
Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression.

Front Endocrinol (Lausanne). 2022

[5]
Public health impact of covid-19 vaccines in the US: observational study.

BMJ. 2022-4-27

[6]
Effectiveness of COVID-19 vaccines in older adults in Colombia: a retrospective, population-based study of the ESPERANZA cohort.

Lancet Healthy Longev. 2022-4

[7]
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022.

MMWR Morb Mortal Wkly Rep. 2022-3-25

[8]
Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar.

JAMA Intern Med. 2022-2-1

[9]
A systematic review of racial/ethnic and socioeconomic disparities in COVID-19.

Int J Equity Health. 2021-11-24

[10]
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.

JAMA. 2021-11-23

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索